The European Medicines Agency (EMEA) has adopted the first positive opinion recommending the granting of a Community authorisation for a mock-up pandemic influenza vaccine. The objective behind a mock-up vaccine is to have a marketing authorisation in place that can be changed quickly in the event of a pandemic to include the virus strain responsible, once it has been identified. [click link for full article]
More...